These findings suggest that the high expression of FABP4 in tumors and increased serum FABP4 levels may be associated with PCa progression through the generation of reactive PCa stroma in PCa patients rather than the extent of obesity (Figure 6). This evidence concerns the gene FABP4 and obesity due to melanocortin 4 receptor deficiency.